Journals / Astım Allerji İmmünoloji / 2013 / Cilt: 11 - Sayı: 2

İlaç allerjisi tanılı hastalarımızda SF-36 yaşam kalitesi ölçeği sonuçlarımız

Our results on SF-36 quality of life scale in patients diagnosed with drug allergy

Pages
112–117
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In present study it was observed that drug allergy had affected the quality of life of both genders; however its influence over women was more prominent.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Drug allergies are drug-hypersensitivity reactions that are assumed to be seen frequently in practice and affect quality of life considerably.
📊
Key Findings & Data:Materials and Methods: A total of 100 patients, between 18-70 years of age, who referred to our center with drug allergy were evaluated prospectively.
💡
Conclusion & Impact:Conclusion: In present study it was observed that drug allergy had affected the quality of life of both genders; however its influence over women was more prominent.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Drug allergies are drug-hypersensitivity reactions that are assumed to be seen frequently in practice and affect quality of life considerably. The aim of this study is to investigate the effect of drug- allergy on quality of life. Materials and Methods: A total of 100 patients, between 18-70 years of age, who referred to our center with drug allergy were evaluated prospectively. During assessment of patients, a questionnaire including socio-demographic characteristics and a Short Form-36 (SF-36) Quality of Life Scale were used. Results: Of our patients 76% were women, 24% were males and mean age was 38.56 ± 11.03 years. The physical, social and emotional role components of SF-36 were found to be decreased in all areas in women. When the score dispersion of quality of life subscale according to education level was examined, the “physical function” subscale was found lower only in elementary school and lesser education areas. Conclusion: In present study it was observed that drug allergy had affected the quality of life of both genders; however its influence over women was more prominent.

Özet

Giriş: İlaç allerjileri pratikte sıklıkla karşılaşılan ve yaşam kalitesini oldukça etkilediği tahmin edilen ilaç hipersensitivite reaksiyonlarıdır. Bu çalışmanın amacı, ilaç allerjisinin yaşam kalitesi üzerine etkisini araştırmaktır. Gereç ve Yöntem: İlaç allerjisi nedeniyle merkezimize başvuran 18-70 yaş arası 100 hasta prospektif olarak değerlendirildi. Hastaların değerlendirilmesinde sosyodemografik özelliklerini içeren soru formu ve Kısa Form-36 (SF-36) Yaşam Kalitesi Ölçeği kullanıldı. Bulgular: Hastalarımızın %76’sının kadın, %24’ünün erkek, yaş ortalamasının 38.56 ± 11.03 yıl olduğu gözlendi. SF-36’nın fiziksel, sosyal, duygusal rol bileşenlerinin kadın hastalarda tüm alanlarda düştüğü saptandı. Eğitim durumuna göre yaşam kalitesi alt ölçek puan dağılımı incelendiğinde yalnızca ilköğretim ve altı eğitim alanlarda “fiziksel fonksiyon” alt ölçeği düşüktü. Sonuç: Bu çalışmada ilaç allerjisinin her iki cinsiyette de yaşam kalitesini etkilediği, fakat bu etkilenmenin kadınlarda daha belirgin olduğu görüldü.

🔖

Cite This Article

BİLGİR, F., BAYRAK, P. D., ÖZGÜL, R. B., DEDE, B., KIRMAZ, C. (2013). İlaç allerjisi tanılı hastalarımızda SF-36 yaşam kalitesi ölçeği sonuçlarımız. Astım Allerji İmmünoloji, Cilt: 11 - Sayı: 2, 112–117. https://ajindex.com/articles/207853

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005;5:309-16
  2. Tahamiler R, Edizer DT, Çanakçıoğlu S. Sürekli alerjik rinit ve etkilenen yaşam kalitesi. Türkiye Klinikleri, J Int Med Sci 2006;2:31-4
  3. The WHO Quality of Life Group. What quality of life? World Health Form 1996;17:354-5
  4. Bergner M, Babbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile development and final revision of a health status measure. Med Care 1981;19:787- 805
  5. Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E. A quantitative approach to perceived health status a validation study. J Epidemol Com Health 1980;34:281-4
  6. Ware JE, Sherbourne CD. The MOS 36-item Short- Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83
  7. Bowling A. Measuring Health: A Review of Quality of Life Measurement Scales. 2nd ed. Philadelphia: Open University Press, 1997:57-60
  8. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 health status questionnaire. J Allergy Clin Immunol 1994;94:182-8
  9. Bahar A, Sertbaş G. Diabetes mellituslu hastalarda yaşam kalitesi ve eğitimi. Sağlık ve Toplum Dergisi 2006;16:29-39
  10. Koçyiğit H, Aydemir Ö, Ölmez N, Memiş A. Kısa form -36 (KF36)’nın Türkçe versiyonunun güvenirliliği ve geçerliliği. İlaç ve Tedavi Dergisi 1999;12:102-6
  11. Demiral Y, Ergör G, Ünal B, Semin S, Akvardar Y, Kıvırcık B, et al. Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health 2006;9:247
  12. Ditto AM. Drug Allergy, Grammer L, Greenberger P, Patterson S (eds). Allergic Diseases. 6th ed. Philadelphia: Lippincott Company, 2002:295-334
  13. Adkinson NF. Drug allergy. Middleton E (ed). Allergy Principles and Practice. 6th ed. Philadelphia: The Mosby Company, 2003:1679-94
  14. Adkinson F, Pangracic J. Drug allergy. Holgate S, Church M, Lichenstein L (eds). Allergy. In: 2nd ed. London: Mosby International Limited, 2001:155-62
  15. Demoly P, Gomes ER. Drug hypersensitivities, definition, epidemiology and risk factors. Allergy Immunol (Paris) 2005:37:202 16. Greenberger P. Allergic reactions to individual drugs. In: Grammer L, Greenberger P, Patterson S (eds). Allergic Diseases. 6th ed. Philadelphia: Lippincott Company, 2002;335-59
  16. Asero R. Detection of patients with multiple drug